← All organizations
Highest phase reached
Phase 3
First clinical trial
Mar 1, 2004Last known activity
Jul 1, 2013
Timeline
1980s
- Jan 1, 1985
Chu De Liège— Founded
Drugs by trial phase (7 distinct, 7 trials)
Phase 3 (2 own, 0 via acquisition)
Phase 2 (5 own, 0 via acquisition)
Indications
Studied for
- Autoimmune Diseases
- Crohn Disease
- Graft vs Host Disease
- Hodgkin Disease
- Leukemia
- Leukemia, Lymphocytic, Chronic, B-Cell
- Leukemia, Lymphoid
- Leukemia, Myelogenous, Chronic, BCR-ABL Positive
- Leukemia, Myeloid
- Leukemia, Myeloid, Acute
- Liver Failure
- Lymphoma, Non-Hodgkin
- Multiple Myeloma
- Myelodysplastic Syndromes
- Myeloproliferative Disorders
- Neoplasms
- Precursor Cell Lymphoblastic Leukemia-Lymphoma
- Renal Insufficiency
Recent trials (10)
- NCT01903473Overall official - principal investigatorPhase 2Jul 1, 2013
- NCT01540292Study chairPhase 1/Phase 2Mar 1, 2012
- NCT01540292Overall official - principal investigatorPhase 1/Phase 2Mar 1, 2012
- NCT01429038Overall official - principal investigatorPhase 1/Phase 2Feb 1, 2012
- NCT01045382Study chairPhase 2Jul 1, 2010
- NCT01045382Overall official - principal investigatorPhase 2Jul 1, 2010
- NCT00603330Study chairPhase 2Jan 1, 2008
- NCT00603954Study chairPhase 2Dec 1, 2007
- NCT00557817Overall official - principal investigatorPhase 2/Phase 3Mar 1, 2004
- NCT00557817Study chairPhase 2/Phase 3Mar 1, 2004
Details
- Founded
- Cork, BE Jan 1, 1985
- Last known activity
- Jul 1, 2013